sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
United States Insulin Pump Market Size Share Opportunity Analysis Growth Potential & Demand Forecast 2017 - 2022

United States Insulin Pump Market Size Share Opportunity Analysis Growth...

Home / Categories / Healthcare
United States Insulin Pump Market Size Share Opportunity Analysis Growth Potential & Demand Forecast 2017 - 2022
United States Insulin Pump Market...
Report Code
RO1-101-512

Publish Date
10/Jul/2017

Pages
145
PRICE
$ 1350/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 1850/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 1850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Table of Contents

1. Executive Summary

2. United States Diabetes Population (2011 – 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes

3. United States Insulin Pump Market Analysis (2011–  2022)
3.1 Insulin Pump Users
3.1.1 Type 1 Diabetes Insulin Pump Users
3.1.2 Type 2 Diabetes Insulin Pump Users
3.2 Insulin Pump Market

4. Key Drivers and Inhibitors of the United States Insulin Pump Market
4.1 Market Drivers
4.1.1 Potential Benefits of Insulin Pump over Multiple Daily Injection
4.1.2 Impact of Advances in Technology
4.1.3 Trendy Pros of Insulin Pump
4.1.4 Growing Spending on Diabetes Management & Worldwide per Capita Healthcare Expending
4.2 Inhibitors
4.2.1 Healthcare Reform Laws Could Adversely Affect the Insulin Pump Market
4.2.2 Safety Issues in Insulin Pump Devices

5. United States Insulin Pump Preferred Brand – By Product
5.1 Pediatric
5.2 Adult

6. United States Insulin Pump Market: Reimbursement & Regulation System
6.1 Reimbursement System
6.2 Regulation System

7. United States Insulin Pump Market – Major Deal Types
7.1 Insulin Pump Market – Collaboration Deals
7.2 Insulin Pump Market – Licensing Agreement
7.3 Insulin Pump Market – Exclusive Agreement
7.4 Insulin Pump Market – Partnerships Deals

8. Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
8.1 Year 2016
8.2 Year 2015
8.3 Year 2014
8.4 Year 2013
8.5 Year 2012

9. Key Companies Analysis
9.1 Medtronic
9.1.1 Business Overview
9.1.2 Insulin Pump – Product Details
9.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.1.4 Insulin Pump – Latest Development & Trends
9.2 Tandem Diabetes Care
9.2.1 Business Overview
9.2.2 Insulin Pump – Product Details
9.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022)
9.2.4 Insulin Pump – Latest Development & Trends
9.3 Insulet Corporation
9.3.1 Business Overview
9.3.2 Insulin Pump – Product Details
9.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022)
9.3.4 Insulin Pump – Latest Development & Trends
9.4 Animas Corporation (Johnson & Johnson)
9.4.1 Business Overview
9.4.2 Insulin Pump – Product Details
9.4.3 Johnson & Johnson – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.4.4 Insulin Pump – Latest Development & Trends
9.5 Roche
9.5.1 Business Overview
9.5.2 Insulin Pump – Product Details
9.5.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022)
9.5.4 Insulin Pump – Latest Development & Trends

List of Tables

Table 4 1: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
Table 7 1: Collaboration Deals in Insulin Pump Market, 2009 – 2016
Table 7 2: Licensing Agreement in Insulin Pump Market, 2015 – 2016
Table 7 3: Exclusive Agreement in Insulin Pump Market, 2011 – 2017
Table 7 4: Partnerships Deals in Insulin Pump Market, 2010 – 2017

List of Figures

Figure 2 1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2 2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2 3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2 4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2 5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2 6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2 7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2 8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 3 1: United States – Insulin Pump Users (Number), 2011 – 2016
Figure 3 2: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 3 3: United States – Type 1 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3 4: United States – Forecast for Type 1 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3 5: United States – Type 2 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3 6: United States – Forecast for Type 2 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3 7: United States – Insulin Pump Market (Million US$), 2011 – 2016
Figure 3 8: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 5 1: United States –  Pediatric Insulin Pump Preference by Product(Percent),2016
Figure 5 2: United States –  Adult Insulin Pump Preference by Product(Percent),2016
Figure 9 1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9 2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9 3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
Figure 9 4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9 5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
Figure 9 6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9 7: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9 8: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9 9: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
Figure 9 10: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com